자동 유방 초음파 시스템(ABUS) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Automated Breast Ultrasound Systems Market size is expected to reach USD 9.69 Billion in 2034 from USD 2.97 Billion (2025) growing at a CAGR of 14.06% during 2026-2034.

The global automated breast ultrasound systems (ABUS) market is positioned for expansion as demand for early cancer detection and advanced diagnostic imaging grows. ABUS is increasingly being deployed as a complementary modality to mammography, particularly for women with dense breast tissue where conventional imaging may lack accuracy. Integration of high-resolution 3D imaging, automated scanning protocols, and AI-based interpretation tools is enhancing diagnostic confidence and reducing inter-operator variability.

Healthcare providers are prioritizing ABUS solutions for their efficiency, reduced examination time, and capability to handle high patient throughput. Continuous improvements in ultrasound transducer technology, image reconstruction algorithms, and user-friendly interfaces are expanding clinical adoption across hospitals, diagnostic centers, and breast care clinics. The combination of automation with cloud-based data storage and telemedicine platforms is further broadening access to advanced imaging in both developed and emerging markets.

Looking forward, advances in deep learning-based detection algorithms, multi-modality integration with MRI and digital mammography, and real-time 4D imaging will elevate ABUS to the next level of diagnostic precision. The market is expected to benefit from public screening programs, rising awareness of preventive healthcare, and the ongoing push for personalized medicine. With technological innovation and global health initiatives converging, ABUS will remain a pivotal tool in reducing breast cancer mortality rates worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Automated Breast Volume Scanner
• Automated Breast Ultrasound (ABUS)

By End Use

• Hospital
• Diagnostics Imaging Laboratories
• Others

COMPANIES PROFILED

• GE HealthCare, Koninklijke Philips NV, Siemens Healthcare Private Limited, Canon Medical Systems Corporation, Telemed Medical Systems srl, Hologic Inc, SuperSonic Imagine, Lunit Inc, Delphinus Medical Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Automated Breast Volume Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Automated Breast Ultrasound (ABUS) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostics Imaging Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 GE HealthCare
  • 8.2.2 Koninklijke Philips N.V
  • 8.2.3 Siemens Healthcare Private Limited
  • 8.2.4 Canon Medical Systems Corporation
  • 8.2.5 Telemed Medical Systems Srl
  • 8.2.6 Hologic Inc
  • 8.2.7 SuperSonic Imagine
  • 8.2.8 Lunit Inc
  • 8.2.9 Delphinus Medical Technologies Inc